Neurological syndromes of organophosphorus compounds

Adverse Drug Reactions and Toxicological Reviews

Volumn 16, Issue 3, 1997, Pages 133-170

  Jamal, Goran A ^a  

^a NHS GREATER GLASGOW AND CLYDE   (United Kingdom)

Author keywords

Autonomic nervous system; Cognitive dysfunction; Electroencephalography; Electromyography; Evoked potentials; Insecticides; Jitter; Nerve conduction; Neurobehavioural; Neurological; Neuromuscular junction; Neuropathy; Neurophysiology; Neurotoxicity; Organophosphates; Psychiatric; Quantitative sensory tests; Single fibre emg

Indexed keywords

ACETYLCHOLINESTERASE; NEUROTOXIC ESTERASE; ORGANOPHOSPHORUS COMPOUND;

AUTONOMIC NEUROPATHY; BEHAVIOR DISORDER; CHOLINERGIC SYSTEM; CHRONIC FATIGUE SYNDROME; CLINICAL FEATURE; DISEASE COURSE; DISEASE MARKER; ELECTROENCEPHALOGRAM; HUMAN; INTOXICATION; MENTAL DISEASE; NEUROLOGIC DISEASE; NEUROMUSCULAR SYNAPSE; NEUROPATHY; NONHUMAN; PERIPHERAL NEUROPATHY; REVIEW; TOXICITY TESTING;

ANIMALS; CENTRAL NERVOUS SYSTEM DISEASES; CHOLINESTERASE INHIBITORS; ELECTROENCEPHALOGRAPHY; HUMANS; INSECTICIDES; ORGANOPHOSPHORUS COMPOUNDS; PERIPHERAL NERVOUS SYSTEM DISEASES; SYNDROME;

EID: 0031405189     PISSN: 0964198X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (163)

1. Edmunson RS. Directory of organophosphorus compounds. Chapman & Hall: London, 1988.
2. Holmstedt B, Structure-activity relationship of the organophosphorus anticholinesterase agents. In: Koelle GB (ed), Handbuch der experimentellen Pharmakologie, cholinesterases and anticholinesterases agents. Springer Verlag: Berlin, P430.
3. Ecobichon DJ, Ozere RL, Reid E, Crocker JFS. Acute fenitrothion poisoning. Can Med Assoc J 1977; 116: 377-86.
4. Abou-Donia MB, Lapadula DM. Mechanisms of organophosphorus ester-induced delayed neurotoxicity: type I and type II. Ann Rev Pharmacol Toxicol 1990; 30: 405- 40.
5. Marrs TC. Organophosphate poisoning. Pharmac Therp 1993; 58: 51-66.
6. Jamal GA. Long-term neurotoxic effects of organophosphate compounds. Adverse Drug React Toxicol Rev 1995; 14: 85-99.
7. Taylor P. Anticholinesterase agents. In: Gilman AG, Goodman LS, Gilman A (eds), Goodman and Gilman's The Pharmacological Basis of Therapeutics. New York: MacMillan, 1980: 100-19.
8. WHO Report: Organophosphorus Insecticides: A General Introduction. WHO: Geneva Environmental Health Criteria 1986: 63.
9. Wadia RS, Chitra S, Amin RB, Kilwalker RS, Sardesai HV. Electrophysiological studies in acute organophosphate poisoning. J Neurol Neurosurg Psychiat 1987; 50: 1442-8.
10. Minton NA, Murray VSG. A review of organophosphate poisoning. Medical Toxicol 1988; 3: 350-75.
11. Osorio AM, Ames RG, Rosenberg J, Mengle DC. Investigation of fatality among parathion applicators in California. Am J Industrial Med 1991; 20: 533-46.
12. Stokes L, Stark A, Marshall E, Narang A. Neurotoxicity among pesticide applicators exposed to organophosphates. Occup Environ Med 1995; 52: 648-53.
13. Ecobichon DJ, Joy RM. Pesticides and Neurological Diseases. Second edn, CRC Press: Boston & London, 1994.
14. Kurtz PJ. Dissociated behavioural and cholinesterase decrements following malathion exposure. Toxicol Appl Pharmacol 1977; 42: 374-9.
15. Haddad L, Winchester J. Clinical Management of Poisoning and Overdose, Philadelphia: WB Saunders, 1983.
16. Henry J. Todd-Sanford-Davidson. Clinical Diagnosis by Laboratory Methods, Philadelphia: WB Saunders, 1984.
17. Midtling J, Barnett P, Coye M, et al. Clinical management of field worker organophosphate poisoning. West J Med 1985; 142: 514-18.
18. Hodgson M, Parkison D. Diagnosis of organophosphate intoxication. N Engl J Med 1985; 313: 329.
19. US Army Environmental Hygiene Agency. Behavioural and Biochemical Effects of Malathion Study No. 51-051-73/76, 1976.
20. Peedicayil J, Ernest K, Thomas M, Kangasabapathy AS, Stephen PM. The effect of organophosphorus compounds on serum pseudocholinesterase levels in a group of industrial workers. Human Exp Toxicol 1991; 10: 275-8.
21. Spiegelberg U. Psychopathologisch-Neurologische Schaden nach Einwirkung Synthetischer Gifte Wehrdienst und Gesundheit, Vol III, Darmstaedt, Wehr und Wissen, Verlagsgesellschaft mbH, 1961.
22. Senanayake N, Sanmuganathan PS. Extrapyramidal manifestations complicating organophosphate insecticide poisoning. Human Exp Toxicol 1995; 14: 600-4.
23. Ochio G, Watanabe KI, Tokuoka H, Hatakenaka S, Arai T. Neuroleptic malignant like syndrome: a complication of acute organophosphate poisoning. Can J Anaesth 1995; 42: 1027-30.
24. Senanayake N, Karallidde L. Neurotoxic effects of organophosphorus insecticides. An intermediate syndrome. New Eng J Med 1987; 316: 761-3.
25. Sedgwick EM, Senanayake N. Pathophysiology of the intermediate syndrome of organophosphate poisoning. J Neurol Neurosurg Psychiat 1997; 62: 201-2.
26. Davis CS, Richardson RJ. Organophosphorus compounds. In: Spencer PS, Schaumburg HH (eds). Experimental and Clinical Neurotoxicology, Baltimore: Williams and Wilkins, 1980: 527-44.
27. Lotti M, Becker CE, Aminoff J. Organophosphate polyneuropathy: pathogenesis and prevention. Neurology (Clev) 1984; 34: 658-62.
28. Cherniack MG. Organophosphorus esters and polyneuropathy. Ann Int Med 1986; 104: 264-6.
29. Johnson MK. Organophosphates and delayed neuropathy - is NTE alive and well? Toxicol Appl Pharmacol 1990; 102: 385-99.
30. Schaumburg HH, Berger AR, Human toxic neuropathy due to industrial agents. In: Dyck PJ, Thomas PK (eds). Peripheral Neuropathy. London: Saunders, 1993: 1533- 48.
31. Lotti M, Moretto A, Zoppellari R, Dainese R, Barusco G. Inhibition of lymphocyte neuropathy target esterase predicts the development of organophosphate induced delayed poly neuropathy. Arch Toxicol 1986; 59: 176-9.
32. Schwab BW, Richardson RJ. Lymphocyte and brain neurotoxic esterase: dose and time dependence of inhibition in the hen examined with three organophosphate esters. Toxicol Appl Pharmacol 1986; 83: 1-9.
33. Abou-Donia MD. Organophosphorus ester-induced delayed neurotoxicity. Ann Rev Pharmacol Toxicol 1981; 21: 511-48.
34. Baker T, Lowndes HE, Johnson MK, Sandborg IC. The effects of phenylmethanesulfonyl flouride on delayed organophosphorus neuropathy. Arch Toxicol 1980; 46: 305-11.
35. Bouldin TW, Cavanagh JB. Organophosphorus neuropathy. I. A teased fibre study of the spatiotemporal spread of axonal degeneration. Am J Pathol 1979; 94: 241-52.
36. Bouldin TW, Cavanagh JB: Organophosphorus neuropathy. II. A fine structural study of the early stages of axonal degeneration. Am J Pathol 1979; 94: 253-70.
37. Ahmed MM, Glees P. Neurotoxicity of tricresylphosphate (TCP) in slow loris (Nycticebus coucang coucang). Acta Neuropathol (Berl) 1971; 19: 94-8.
38. Abou-Dorua MB. Delayed neurotoxicity of phenylphosphonothioate esters. Science 1979; 205: 713-15.
39. Cherniack M. Toxicological screening for organophosphorus induced delayed neurotoxicity. Neurotoxicology 1988; 9: 249-72.
40. Moen BE: Environmental and occupational toxins. Curr Opin Neurol Neurosurg 1991; 4: 442-6.
41. Spencer PS, Schaumburg HH. Pathobiology of neurotoxic axonal degeneration. In: Waxman SG (ed), Physiology and Pathophysiology of Axons, New York: Raven Press, 1978: 265-82.
42. De Rojas TC, Goldstein BD. Lack of evidence for the size principle of selective vulnerability of axons in toxic neuropathies. Toxicol Appl Pharmacology 1990; 104: 47-58.
43. Kaplan JG, Kessler J, Rosenberg N, Pack D, Schaumberg HH. Sensory neuropathy associated with Dursban (chlorpyrifos) exposure. Neurology 1993; 43: 2193-6.
44. Lotti M. The pathogenesis of organophosphate delayed neuropathy. Crit Rev Toxicol 1992; 21: 465-87.
45. Karczmar AG. Acute and long lasting central actions of organophosphorus drugs. Fundam Appl Toxicol 1984; 4: S1-S17.
46. Abou-Donia MB, Wilmarth KR, Jansen KF, Farr CH. Triphenylphosphine (TPP): A type III Organophosphorus compound-induced delayed neurotoxic agent (OPIDN). The Toxicologist 1996; 30: 311.
47. Abdel-Rahman AA, Jansen KF, Farr CH, Abou-Donia MB. Daily treatment of triphenylphosphine (TPP) produces organophosphorus induced delayed neurotoxicity (OPIDN). Abstract presented at Annual SOT meeting. March 1997.
48. Abou-Donia MB, Wilmarth KR, Abdel-Rahman AA, Jenson KF, Oheme FW, Kurt TL. Increased neurotoxicity following cocurrent exposure to pyridostigmine bromide, DEET, and chlorpyrifos. Fundam Appl Toxicol 1996; 34: 201-22.
49. Curtes JP, Develay P, Hubert JP. Late peripheral neuropathy due to acute voluntary intoxication by organophosphorus compounds. Clin Toxicol 1981; 18: 1453.
50. de Jager AEJ, van Weerden TW, Houthof HJ, de Monchy JGR. Polyneuropathy after massive exposure to parathion. Neurology 1981; 31: 306.
51. Stamboulis E, Psimaras A, Vassilopoulos D, et al. Neuropathy following acute intoxication with mecarbam (Opester). Acta Neurol Scand 1991; 83: 198.
52. Lotti M, Moretto A, Capodisaca E, et al. Interactions between NTE and its inhibitors and the development of neuropathy. Toxicol Appl Parmacol 1993; 122: 165-71.
53. Lotti M. The pathogenesis of organophosphate polyneuropathy in humans: perspectives for biomonitoring. Trends Pharmacol Sci 1987; 8: 175-9.
54. Richardson R. Interactions of organophosphorus compounds with neurotoxic esterase. In: Chambers J, Levi P (eds), Organophosphates, San Diego: Academic Press, 1992; 299-23.
55. Lotti M, Caroldi S, Moretto A. Promotion of organophosphate induced delayed polyneuropathy by phenylmethansulfonyl flouride. Toxicol Appl Pharmacol 1991; 108: 234-41.
56. Lotti M, Moretto A, Bertolazzi M, et al. Organophosphate polyneuropathy and NTE. Arch Toxicol 1995; 69: 330-6.
57. Pope CM, Padilla S. Potentiation of organophosphorus-induced delayed neurotoxicity by phenylmethyisulfonyl flouride. J Toxicol Environ Health 1990; 31: 261-73.
58. Johnson MK. A phosphorylation site in brain and delayed neurotoxic effect of organophosphorus compounds. Biochem J 1969; 111: 487-95.
59. Moretto A, Bertolazzi M, Capodicase E, et al. Phenylmethanesulphonyl flouride elicits and intensifies the clinical expression of neuropathic insults. Arch Toxicol 1992; 66: 67-72.
60. Moretto A, Bertolazzi M, Lotti M. The phosphorothioic acid O-( 2-chloro-2,3,3,- triflourocyclobutyl) O-ethyl ester exacerbates organophosphate polyneuropathy without inhibition of neuropathy target esterase. Toxical Appl Pharmacol 1994; 129: 133-7.
61. Aldridge A. Postscript to symposium on organophosphorus compound induced delayed neuropathy. Chemico-Biological interactions 1993; 87: 463-6.
62. Marrs TC. An overview of delayed effects of organophosphates. Proceedings of Conference Report Seminar NFU/BMA, The Royal Society, June 1995; 8-10.
63. Jamal GA. The impact of OPs on nervous system. Proceedings of Conference Report Seminar BMA/NFU, The Royal Society, June 1995.
64. Steenland K, Jenkins B, Ames RG, O'Malley M, Chrislip D, Russo J. Chronic neurological sequelae to organophosphate pesticide poisoning. Am J Public Health 1994; 84: 731-6.
65. Beach JR, Spurgeon A, Stephens R, Heafield T, Calveri IA, et al. Abnormalities on neurological examination among sheep farmers exposed to organophosphate pesticides. Occup Environ Med 1996; 53: 520-5.
66. Kelly SS, Ferry CB, Bamforth JP. The effects of anticholinesterases on the latencies of action potentials in mouse skeletal muscles. Br J Pharmacol 1990; 99: 721-6.
67. Kelly SS, Mutch E, Williams FM, Blain PG. Electrophysiological and biochemical effects following single doses of organophosphates in the mouse. Arch Toxicol 1994; 68: 459-66.
68. Kelly SS, DeBlaquiere GE, Williams FM, Blain PG. Effects of multiple doses of organophosphates on evoked potentials in mouse diaphragm. Human Exp Toxicol 1997; 16: 72-8.
69. Baker DJ, Sedgwick EM. Single fibre electromyographic changes in man after organophosphate exposure. Human Experiment Toxicol 1996; 15: 369-75.
70. Jamal GA (Editorial). Long-term neurotoxic effects of chemical warfare organophosphate compounds (Sarin). Adverse Drug. Reaction Toxicol Rev 1995; 14: 83-4.
71. Kadar T, Shapira S, Cohen G, Sahar R, Alkalay D, Raveh L. Sarin induced neuropathology in rats. Human Exp Toxicol 1995; 14: 252-9.
72. Kawabuchi M, Cintra WM, Despande SS, Albuquerque EX. Morphological and electrophysiological study of distal motor nerve fibre degeneration and spouting after irreversible cholinesterase inhibition. Synapse 1991; 8: 218-28.
73. Goldstein BD, Fincher DR, Searle JR. Electrophysiological changes in the primary sensory neurone following subchronic Soman and Sarin: alteration in sensory receptor function. Toxical Appl Pharmacol 1987; 91: 55-64.
74. Hussain K, Vijayaragharan R, Pant SC, Raza SK, Pandey KS. Delayed neurotoic effect of Sarin I mice after repeated inhalation exposure. J Appl Toxicol 1993; 13: 143-5.
75. Steenland M. Chronic neurological effexts of organophosphate pesticides. Brit Med J 1996; 312: 1311-12.
76. Savage EP, Keefe TF, M ounce LM, Heaton RK, Lewis JA, Burcar PJ. Chronic neurological sequelae of acute organophosphate pesticide poisoning. Arch Environ Health 1988; 43: 38-45.
77. Rosenstock L, Keifer M, Daniell W E, McConnell R, Claypoole K. Chronic central nervous system effects of acute organophosphate pesticide intoxication. Lancet 1991; 338: 223-7.
78. Rosenstock L, Daniell WE, Barnhart S, Schwartz D, Demers PA. Chronic neuropsychological sequelae of occupational exposure to organophosphate insecticide. Am J Industr Med 1990; 18: 312-25.
79. McConnell R, Keifer M, Rosenstock L. Elevated quantitative vibrotactile threshold among workers previously poisoned with methamidophos and other organophosphate pesticides. Am J Indust Med 1994; 25: 325-34.
80. Ames R, Steenland K, Jenkins B, Chrislop D, Russo J. Chronic neurologic sequelae to cholinesterase inhibition among agricultural pesticide applicators. Arch Environ Health 1995; 50: 440-3.
81. Grob D, Garlick WL, Harvey AM. The toxic effects in man of parathion (p- nitrophenyl diethyl thiophosphate). Bull Johns Hopkins Hosp 1950; 87: 106-29.
82. Dille JR, Smith PW. Central nervous system effects of chronic exposure to organophosphate insecticides. Aerosp Med 1964; 35: 475-8.
83. Whorton MD, Obrinsky DL. Persistence of Symptoms after mild to moderate acute organophosphate poisoning among 19 farm field workers. J Toxicol Environ Health 1983; 11: 347-54.
84. Tabershaw IR, Cooper WC. Sequelae of acute organic phosphate poisoning. J Occup Med 1966; 8: 5-20.
85. Faerman IS. After effects of acute poisoning with organophosphorus insecticides. Gig Tr Prof Zabol 1967; 4: 39-54.
86. Murray VSG, Wiseman HM, Dawling S, Morgan I, House IM. Health effects of organophosphate sheep dips. Brit Med J 1992; 305: 1090.
87. Sims P. Health effects of organophosphate sheep dips. Brit Med J 1992; 305: 1503.
88. Sherman JD. Organophosphate pesticides-neurological and respiratory toxicity. Toxicol Indust Health 1995; 11: 33-9.
89. D'Mello GD. Neurobehavioural toxicology of anticholinesterases. In: Ballantyne B, Marrs TC (eds), Clinical and Experimental Toxicology of Organophosphates and Carbamates, Oxford: Butterworth, 1992, P61-74.
90. Duffy FH, Burchfiel JL. Long-term effects of the organophosphate Sarin on EEG in monkeys and humans. Neurotoxicology 1980; 1: 667-89.
91. Mutch E, Blain PG, Williams FM. Inter-individual variations in enzymes controlling organophosphate toxicity in man. Human Exp Toxicol 1992; 11: 109-16.
92. Metcalf DR, Holmes JH. EEG, psychological and neurological alterations in humans with organophosphorus exposure. Ann N Y Acad Sci 1969; 160: 357-65.
93. Durham WF, Wolfe HR, Quinby GE. Organophosphorus insecticides and mental alertness. Arch Environ Health 1965; 10: 55-66.
94. Namba T, Notle CT, Jackrel J, et al. Poisoning due to organophosphate insecticides acute and chronic manifestations. Am J Med 1971; 50: 475-92.
95. Smith PW, Stavinoha WB, Ryan LC. Cholinesterase inhibition in relation to fitness to fly. Aerosp Med 1968; 39: 754.
96. Woods W, Gavica J, Brown W, Watson M, Benson W. Implications of organophosphate pesticide poisoning in the plane crash of a duster pilot. Aerosp Med 1971; 42: 1111.
97. Levin HS, Rodnitzky RL, Mick DL. Anxiety associated with exposure to organophosphate compounds. Arch Gen Psychiat 1976; 33: 225-8.
98. Rodnitzky RL, Levin HS, Mick DL. Occupational exposure to organophosphate pesticides. A neurobehavioural study. Arch Environ Health 1975; 30: 98-103.
99. Maizlish N, Schenker M, Weisskopf C, Seiber J, Samuels S. A behavioural evaluation of pest control workers with short-term, low-level exposure to the organophosphate diazinon. Am J Indust Med 1987; 12: 153-72.
100. Burger M, Alonzo C, Heuhs L, Laborde A, Lqcuague J, Alfonso L. Poly neuropathy due to organophosphorus pesticides (French article). Arch Mal Prof (Paris) 1991; 52: 37-8.
101. Stephens R, Spurgeon A, Calvert IA, Beach J R, Levy L S, Berry H, Harrington M. Neuropsychological effects of long-term exposure to organophosphates in sheep dip. Lancet 1995; 345: 1135-9.
102. Jamal GA, Hansen S, Apartopoulos F, Peden A, Ballantyne JP. Peripheral nerve dysfunction in organophosphate compounds (unpublised data) 1997.
103. Meerdink GL. Organophosphorus and carbamate insecticide poisoning in large animals. Vet Clin North Am Food Anim Pract 1989; 5: 375-89.
104. Hogstedt C, Anderson K, Hane MA. A questionnaire approach to the monitoring of early disturbances in central nervous function. In: Aito R, Riinimaki K, Vainio H (eds), Biological Monitoring and Surveillance of Workers Exposed to Chemicals, Washington: Hemisphere Publishing, 1984.
105. Gershon S, Shaw FB. Psychiatric sequelae of chronic exposure to organophosphate insecticides. Lancet 1961; 1: 1371-4.
106. Costa LG. Organophosphorus compounds. In: Galli C L, Manzo L, Spencer P S (eds), Recent Advances in Nervous System Toxicology, Plenum: New York, 1988: 203-46.
107. Upchurch M, Wehner JM. Effects of di-isopropylfluorophosphate on spatial learning in mice. Pharmacol Biochem Behav 1987; 27: 143-51.
108. McDonald BE, Costa LG, Murphy SD. Spatial memory impairment and central muscarinic receptor loss following prolonged treatment with organophosphates. Toxicol Letters 1988; 40: 47-56.
109. Stamper CR, Balduini W, Murphy SD, Costa LG. Behavioural and biochemical effects of postnatal parathion exposure in the rat. Neurotoxicol Teratol 1988; 10: 261-6.
110. Fitzgerald B, Costa LG. Modulation of muscarinic receptors and acetylcholinesterase activity in lymphocytes and in brain areas following repeated organophosphate exposure in rats. Fundam Appl Toxicol 1993; 20: 210-16.
111. Bushnell PJ, Padilla SS, Ward T, Pope CN, Olszyk VB. Behavioural and neurochemical changes in rats dosed repeatedly with di-isopropylflourophosphate. J Pharmacol Exp Therap 1991; 256: 741-50.
112. Rowntree DW, Nevin S, Wilson A. The effects of di-isoprophylflourophosphate in schizophrenia and manic depressive psychoses. J Neurol Neurosurg Psychiat 1950; 13: 47-62.
113. Grob D, Harvey AM, Langworthy OR, Lilienthal JL. The administration of di- isopropylfluorophosphate (DFP) to man: III. Effects on the central nervous system with special reference to electrical activity of the brain. Bull Johns Hopkins Hosp 1947; 81: 257-66.
114. Bidstrup PL, Bonnell JA, Beckett AG. Paralysis following poisoning by a new organic phosphorus insecticide (Mipafox). Br Med J 1953; 1: 1068-72.
115. Barnes PL. Psychiatric equelae of chronic exposure to organophosphorus insecticides. Lancet 1961; II: 102-3.
116. Bidstrup PL. Psychiatric sequelae of chronic exposure to organophosphorus insecticides. Lancet 1961; II: 103.
117. Stoller A, Krupinski J, Christophers AJ, Blanks GK. Organophosphate insecticides and major mental illness. Lancet 1965; 1: 1387-8.
118. Hayes WJ, Dixon EM, Batchelor GS, Upholt WM. Exposure to organic phosphorus sprays and occurrence of selected symptoms. Public Health Rep 1959; 72: 787-92.
119. West I. Sequelae of poisoning from phosphate ester pesticides. Ind Med Surg 1968; 37: 832.
120. Davies DR. Organophosphate affective disorders and suicide. J Nutrit Environ Med 1995; 5: 367-74.
121. Parron T, Hernandez AT, Villanueva E. Increased risk of suicide with exposure to pesticides in an intensive agricultural area: A 12 year retrospective study. Forensic Science International 1996; 79(1): 53-63.
122. Ahmed GA, Davies DR. Chronic organophosphate exposure toward the difinition of a neuropsychiatric syndrome. J Nutrit Environ Med (in press).
123. Davies DR. Avalon Hospital NHS Trust. Personal communication (1997).
124. Hillyard SA, Kutas M. Electrophysiology of cognitive processing. Ann Rev Psychol 1983; 34: 33-41.
125. Sutton S, Ruchkin DS. The late positive complex: Advances and new problems. Ann NY Acad Sci 1984; 425: 1-23.
126. Ritter W, Ford JM, Gaillard AWK, et al. Cognition and event-related potentials. The relation between cognitive potential and cognitive processes. Ann NY Acad Sci 1984; 425: 24-42.
127. Goodwin DS, Squires KC, Star A. Long latency event-related components of the auditory evoked potential in dementia. Brain 1978; 101: 357: 635-42.
128. Syndulko K, Pettler-Jennings P, Cohen SN, et al. P300 in memory disorders of diverse aetiology. Neurology (Suppl 1) 34: 234-9.
129. Butler S. Scientific Director, Burden Neurological Institute, Bristol. Personal communication, 1997.
130. Behan PO, Haniffah BAG. Chronic fatigue syndrome: a possible delayed hazard of pesticide exposure. Clin Infec Dis 1994; 18(suppl 1): S54.
131. Behan PO. Chronic fatigue syndrome as a delayed reaction to low dose organophosphate exposure. J Nutrition Environ Med 1996; 6: 341-50.
132. Krupp LB, Pollina DA. Mechanisms and management of fatigue in progressive neurological disorders. Curr Opin Neurol 1996; 9: 456-560.
133. Dunstan RH, Donohoe M, Taylor W, et al. A preliminary investigation of chlorinated hydrocarbones and chronic fatigue syndrome, Med J Aust 1995; 163: 293-7.
134. Mesh U, Lowenthal RM, Coleman D. Lead poisoning masquerading as chronic fatigue syndrome. Lancet 1996; 347: 1193.
135. Centre for Disease control CDC, US Department of Health and Human Services: Risk factors for chronic fatigue syndrome: a case control study. J Chr Fatigue Synd 1996; 2: 17-33.
136. Chaudhuri A, Majeed T, Dinan T, Behan PO. Chronic fatigue syndrome: a disorder of central cholinergic transmission. J Chr Fatigue Synd 1997; 3: 3-16.
137. Whyte I, Dawson A. A case with chronic frontal lobe syndrome following acute poisoning with diazinon. Personal communication, 1977.
138. Davis KL, Yesavage JA, Berger PA. Possible organophosphate induced parkinsonism. J Nerv Ment Dis 1978; 166: 222-5.
139. Burchfiel JL, Duffy FN, Sim VM. Persistent effects of Sarin and Dieldrin upon the primate EEG. Toxicol Appl Pharmacol 1976; 35: 365-79.
140. Holmes JH. Organophosphorus insecticides in Colorado. Arch Environ Health 1964; 9: 445-53.
141. Duffy FH, Burchfiel JL, Bertels PH, Gaon M, Sim VM. Long-term effects of an organophosphate upon human EEG. Toxicol Appl Pharmacol 1979; 47: 161-76.
142. Burchfiel L, Duffy FH. Organophosphate neurotoxicity: Chronic effects of Sarin on the electroencephalogram of monkey and man. Neurobeh Toxicol Teratol 1982; 4: 767-78.
143. Korsak RJ, Sato MM. Effects of chronic organophosphate pesticide exposure on the central nervous system. Clin Toxicol 1977; 11: 83-95.
144. Rayner MD, Popper JL, Carvalho EW, Hurov R. Hyporeflexia in workers chronically exposed to organophosphate insecticides. Res. Commun Chem Pathol Pharmacol 1972; 4: 595-606.
145. Svendsgaard D, Soliman S, Otto D, et al. Assessment of neurotoxicity in workers occupationally exposed to organophosphate pesticides. Research Triangle Park, NC: US Environment Protection Agency, 1988 (EPA document CR-811178).
146. Arezzo JC, Schaumburg HH, Spencer PS. Structure and function of the somatosensory system; a neurotoxicologic perspective. In: Toxicology of the eye, ear and other special senses, New York: Raven Press, 1985.
147. Fisher JR: Guillain-Barré syndrome following organophosphate poisoning. J Am Med Assoc 1977; 238: 1950-2.
148. Adlakha A, Philip PJ, Dhar KL. Guillain-Barré syndrome as a sequelae of organophosphorus poisoning. J Assoc Physicians India 1987; 35: 665.
149. Sahin M, Bernay I, Canturk F, Demercali AE. Reflex sympathetic dystrophy secondary to organophosphate intoxication induced neuropathy. Ann Nuclear Med 1994; 8: 299-300.
150. Julu PO, Hansen S, Jamal GA. Peripheral Nerve and Autonomic Unit, Institute of Neurological Sciences, Glasgow. Unpublished data, 1997.
151. Healy C, Lequesne PM, Lynn B. Collateral sprouting of cutanous nerves in man. Brain 1996; 119: 2063-72.
152. Davies JE. Neurotoxic concern of human pesticide exposure. Am J Indust Med 1990; 18: 327-31.
153. Landrigan PJ, Graham DG,Thomas RD. Environmental neurotoxic illness. Research and prevention. Environ Health Perspective 1994; 102: 117-20.
154. Hurbert M, Lison D. Study of muscular effects of short-term pyridostigmine treatment in resting and exercising rats. Human Environ Toxicol 1995; 14: 49-54.
155. Friedman A, Kaufer D, Sherner J, Hendler I, Soreq H, Tur-kaspa I. Pyridostigmine brain penetration under stress enhances neuronal excitability and induces early immediate transcriptional response. Nature Med 1996; 2: 1382-5.
156. Jamal GA. Spinal cord physiology and neurophysiological investigation. Curr Opin Neurol Neurosurg 1990; 3: 597-602.
157. Jamal GA. Spinal cord neurophysiology. Curr Opin Neurol 1991; 4: 617-20.
158. Jamal GA, Mann AC. Clinical neurophysiology of peripheral nerve and muscle. Curr Opin Neurol 1993; 6: 724-30.
159. Jamal GA, Weir AI, Hansen S, Ballantyne JP. An improved automated method for the measurement of thermal thresholds. 1. normal subjects. J Neurol Neurosurg Psychiat 1985; 48: 354-60.
160. Jamal GA, Weir AI, Hansen S, Ballantyne JP. An improved automated method for the measurement of thermal thresholds. 2. Patients with peripheral neuropathy. J Neurol Neurosurg Psychiat 1985; 48: 361-6.
161. Jamal GA, Hansen S, Weir AI, Ballantyne JP. The neurophysiologic investigation of small fibre neuropathies. Muscle and Nerve 1987; 10: 537-45.
162. Jamal GA, Hansen S, Ballantyne JP. An automated system for quantification of the sense of vibration in man. J Physiol (Lond) 1991; 438: 340P.
163. LeQuesne PM. Neurophysiological investigation of subclinical and minimal toxic neuropathies. Muscle and Nerve 1978; 1: 392-5.